This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Medicaid Drug Rebate Program (MDRP) Summit 2025
September 15-17, 2025
Delivered as a Hybrid EventFairmont Chicago Millennium Park, Chicago, IL
Book Now
Menu
Book Now
keyboard_arrow_right

Day Three - CT (Central Time)

keyboard_arrow_leftSearch & Filter
search
Day Three - CT (Central Time)
search
Showing 1 of 1 Streams
10:50am - 11:30am
Administration Policy Shifts: Nine Months of Pharmaceutical Industry Impact
  • Investigate the administration's Medicare drug price negotiation approach and IRA implementation, including enforcement changes, compliance requirements, and proposed legislative modifications since January 2025
  • Review how new leadership at HHS, FDA, and CMS affects drug approval pathways and compliance expectations, with insights from industry leaders managing these transitions
  • Assess international reference pricing and tariff policies impacting pharmaceutical imports and manufacturing, including effects on global supply chains and domestic production incentives
  • Explore the administration's healthcare priorities in the 2026 budget proposal and regulatory agenda, with analysis of potential impacts on market access, pricing transparency, and innovation
  • Lisa Clayton - Senior Director, Government Price Reporting, The Pricing Group, LLC
  • Mallory O’Connor - Executive Director, Public Policy, Mallinckrodt Pharmaceuticals
11:35am - 12:15pm
International Reference Pricing: Return and Implications
  • Examine the potential resurgence of international reference pricing policies under the new administration
  • Compare previous attempts at implementation with current proposals and understand key differences
  • Explore potential impacts on global pricing strategies, market access approaches, and launch sequencing
  • Develop strategic frameworks for pharmaceutical pricing in an environment with potential cross-border referencing
  • John Gould - Partner, Arnold & Porter
  • Pari Mody - Partner, Arnold & Porter
Day Two
Filter
Streams
Clear
Formats
Choose Day